Clinical trials
Recruiting Observational Neuroblastoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nanjing First Hospital, Nanjing Medical University | 2 |
| National Cancer Institute (NCI) | 2 |
| St. Jude Children's Research Hospital | 2 |
| Children's Hospitals and Clinics of Minnesota | 1 |
| Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 1 |
| First Affiliated Hospital of Zhejiang University | 1 |
| Guangzhou Women and Children's Medical Center | 1 |
| Ilya Khaytin | 1 |
| Mayo Clinic | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neuroblastoma | 16 |
| Retinoblastoma | 3 |
| Sarcoma | 3 |
| Ganglioneuroblastoma | 2 |
| Ganglioneuroma | 2 |
| Neoplasms | 2 |
| Paraganglioma | 2 |
| Pheochromocytoma | 2 |
| Rhabdomyosarcoma | 2 |
| Sarcoma, Ewing | 2 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.